- Home
- PCVX vs XPEV Comparison
PCVX vs XPEV Comparison
Compare PCVX & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- XPEV
- Stock Information
- Founded
- PCVX 2013
- XPEV 2015
- Country
- PCVX United States
- XPEV China
- Employees
- PCVX N/A
- XPEV N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- XPEV Auto Manufacturing
- Sector
- PCVX Health Care
- XPEV Consumer Discretionary
- Exchange
- PCVX Nasdaq
- XPEV Nasdaq
- Market Cap
- PCVX 13.2B
- XPEV 12.0B
- IPO Year
- PCVX 2020
- XPEV 2020
- Fundamental
- Price
- PCVX $87.47
- XPEV $12.87
- Analyst Decision
- PCVX Strong Buy
- XPEV Buy
- Analyst Count
- PCVX 7
- XPEV 8
- Target Price
- PCVX $147.50
- XPEV $12.46
- AVG Volume (30 Days)
- PCVX 1.1M
- XPEV 12.0M
- Earning Date
- PCVX 11-05-2024
- XPEV 11-19-2024
- Dividend Yield
- PCVX N/A
- XPEV N/A
- EPS Growth
- PCVX N/A
- XPEV N/A
- EPS
- PCVX N/A
- XPEV N/A
- Revenue
- PCVX N/A
- XPEV $5,390,497,248.00
- Revenue This Year
- PCVX N/A
- XPEV $37.32
- Revenue Next Year
- PCVX N/A
- XPEV $62.03
- P/E Ratio
- PCVX N/A
- XPEV N/A
- Revenue Growth
- PCVX N/A
- XPEV 66.09
- 52 Week Low
- PCVX $53.83
- XPEV $6.55
- 52 Week High
- PCVX $121.06
- XPEV $15.68
- Technical
- Relative Strength Index (RSI)
- PCVX 41.78
- XPEV 51.55
- Support Level
- PCVX $86.80
- XPEV $11.98
- Resistance Level
- PCVX $92.94
- XPEV $13.02
- Average True Range (ATR)
- PCVX 3.22
- XPEV 0.52
- MACD
- PCVX 0.44
- XPEV -0.03
- Stochastic Oscillator
- PCVX 33.92
- XPEV 30.65
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.